|Bid||0.1300 x 686300|
|Ask||0.1350 x 26372000|
|Day's range||0.1300 - 0.1350|
|52-week range||0.1250 - 0.3000|
|Beta (5Y monthly)||1.52|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||19 Sep 2005|
|1y target est||N/A|
AusCann Group Holdings Ltd (ASX:AC8), an Australian based pharmaceutical company focused on the development, production and distribution of cannabinoid-based medicines within Australia and internationally, is pleased to announce that it has entered into a scheme implementation deed (SID) with CannPal Animal Therapeutics Limited.
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
AusCann Group Holdings Ltd (ASX:AC8) shareholders should be happy to see the share price up 25% in the last month. But...